Skip to main content
Robert Lober, MD, Neurosurgery, Dayton, OH

Robert Michael Lober MD

Pediatric Neurosurgery


Physician

Join to View Full Profile
  • 1 Childrens PlzDayton, OH 45404

  • Phone+1 937-641-4000

  • Fax+1 937-641-4500

Dr. Lober is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Neurosurgery, 2014 - 2015
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Neurological Surgery, 2008 - 2015
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Neuro-Oncology, 2011 - 2012
  • Stanford Health Care
    Stanford Health CareInternship, Transitional Year, 2008 - 2009
  • Medical College of Georgia at Augusta University
    Medical College of Georgia at Augusta UniversityClass of 2008

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2015 - 2026
  • CA State Medical License
    CA State Medical License 2009 - 2025
  • Neurological Surgery
    American Board of Neurological Surgery Neurological Surgery

Publications & Presentations

PubMed

Press Mentions

  • Myrtelle Announces Positive Data for Its Investigational Proprietary rAAV-Olig001-ASPA Gene Therapy in Canavan Disease at the National Tay Sachs & Allied Diseases Association Conference
    Myrtelle Announces Positive Data for Its Investigational Proprietary rAAV-Olig001-ASPA Gene Therapy in Canavan Disease at the National Tay Sachs & Allied Diseases Association ConferenceJuly 8th, 2022
  • Myrtelle Announces Positive Preliminary Clinical Data for Its Proprietary Gene Therapy in Canavan Disease
    Myrtelle Announces Positive Preliminary Clinical Data for Its Proprietary Gene Therapy in Canavan DiseaseFebruary 15th, 2022
  • New Gene Therapy Trial in US Offers Hope for Children with Canavan Disease
    New Gene Therapy Trial in US Offers Hope for Children with Canavan DiseaseMay 8th, 2021
  • Join now to see all

Grant Support

  • GPCR Lateral Membrane Diffusion In Neuronal SignalingNational Institute Of Neurological Disorders And Stroke2006–2008

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: